ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel

被引：0
|
作者：
Lifeng Wang
Jia Wei
Xiaoping Qian
Haitao Yin
Yang Zhao
Lixia Yu
Tingting Wang
Baorui Liu
机构：
[1] Drum Tower Hospital Affiliated to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University,Department of Oncology
[2] Nanjing Medical University,Department of Epidemiology and Biostatistics, Epidemiology and Biostatistics Graduate Program, Data Analysis Center, School of Public Health
来源：
BMC Cancer | / 8卷
关键词：
Docetaxel; Gastric Cancer Patient; Nucleotide Excision Repair; Malignant Pleural Effusion; BRCA1 Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] BRCA1 and ERCC1mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer
    Lu Yuanming
    Zhang Lineng
    Song Baorong
    Peng Junjie
    Cai Sanjun
    BMC Cancer, 13
  • [22] The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
    Song, Wenhui
    Ma, Hongshun
    ONCOTARGETS AND THERAPY, 2016, 9 : 3465 - 3471
  • [23] RNA EXPRESSION OF XPG, ERCC1 AND BRCA1 IN MYXOID LIPOSARCOMA PATIENTS TREATED WITH NEOADJUVANT TRABECTEDIN
    Gronchi, A.
    Tarantino, E.
    Italiano, A.
    Le Cesne, A.
    Hohenberger, P.
    Hohl, R.
    Benlloch, S.
    Lardelli, P.
    Nieto, A.
    Tercero, J. C.
    ANNALS OF ONCOLOGY, 2010, 21 : 412 - 412
  • [24] ERCC1 Expression and Chemosensitivity in Uterine Cervical Adenocarcinoma Cells
    Torii, Yutaka
    Kato, Rina
    Minami, Yukito
    Hasegawa, Kiyoshi
    Fujii, Takuma
    Udagawa, Yasuhiro
    ANTICANCER RESEARCH, 2014, 34 (1A) : 107 - 115
  • [25] RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin
    Park, Yong
    Kim, Dae S.
    Park, Kyong H.
    Baek, Seung-Kuk
    Kwon, Soon Y.
    Shin, Sang W.
    Jung, Kwang Y.
    Kim, Chul Y.
    Kim, Yeol H.
    Lee, Nam J.
    Kim, Jun S.
    Kim, In S.
    ONKOLOGIE, 2012, 35 (11): : 673 - 682
  • [26] In Situ Protein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy
    Metro, G.
    Zheng, Z.
    Fabi, A.
    Schell, M.
    Antoniani, B.
    Mottolese, M.
    Monteiro, A. N.
    Vici, P.
    Rivera, S. Lara
    Boulware, D.
    Cognetti, F.
    Bepler, G.
    CANCER INVESTIGATION, 2010, 28 (02) : 172 - 180
  • [27] In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-including chemotherapy
    Metro, G.
    Zheng, Z.
    Fabi, A.
    Mottolese, M.
    Monteiro, A. N.
    Vici, P.
    Boulware, D.
    Rivera, S. Lara
    Cognetti, F.
    Bepler, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] ERCC1、BRCA1在胃癌中的研究进展
    梁发
    谢忠
    齐齐哈尔医学院学报, 2011, 32 (02) : 262 - 264
  • [29] ERCC1 MRNA EXPRESSION AND RESPONSE TO CISPLATIN-DOCETAXEL NEOADJUVANT CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER PATIENTS
    Consito, L.
    Buffoni, L.
    Grillo, R.
    Paze, E.
    Barone, C.
    Dongiovanni, D.
    Cristiano, C.
    Birocco, N.
    Ciuffreda, L.
    Schena, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [30] UNIQUE BRCA1, ERCC1 AND TYMS MRNA PROFILES MAY BE RELATED TO NSCLC PATIENT OUTCOME ACCORDING TO DISEASE STAGE
    Kotoula, Vassiliki
    Karavasilis, V.
    Eleftheraki, A. G.
    Televantou, D.
    Papadopoulou, K.
    Charalambous, E.
    Korantzis, I.
    Dimoudis, S.
    Dionysopoulos, D.
    Samantas, Epaminondas
    Papaxoinis, G.
    Skarlos, Dimosthenis-Vassilios
    Pectasides, D.
    Kosmidis, Paris A.
    Fountzilas, G.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1106 - S1107
12345